Form 4: AMN Healthcare CEO's RSU Vesting & Tax Withholding

AMN Healthcare CEO Caroline Grace reported the vesting of Restricted Stock Units and subsequent share disposals for tax purposes under a Rule 10b5-1 plan.

Summary

• Caroline Grace, Chief Executive Officer and Director of AMN Healthcare Services Inc. (AMN), reported transactions involving the company's common stock.
• On November 28, 2025, 2,776 shares of common stock were acquired upon the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Concurrently, 676 shares were disposed of at $17.22 per share to cover tax obligations related to the RSU vesting.
• Additionally, on November 28, 2025, another 5,552 shares of common stock were acquired upon the vesting of RSUs at a price of $0.
• 1,650 shares were disposed of at $17.22 per share for tax withholding purposes.
• These transactions were conducted pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Following these reported transactions, Caroline Grace directly beneficially owns 50,347 shares of AMN Common Stock.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions related to RSU vesting and tax withholding under a pre-arranged plan. While the net effect is an increase in beneficial ownership, the dispositions for tax purposes are standard. No significant positive or negative operational news is conveyed.

Positives

• The acquisition of shares through RSU vesting indicates continued equity ownership and alignment of interests between the CEO and shareholders.
• The transactions were executed under a Rule 10b5-1 plan, suggesting pre-planned and automated transactions rather than discretionary trading.

Negatives

• The disposition of shares, totaling 2,326 shares (676 + 1,650), reduces the CEO's direct beneficial ownership, although this is a standard practice for tax withholding upon RSU vesting.

Future Outlook

The filing primarily reports past and scheduled equity transactions and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, common across all publicly traded companies. It reflects standard executive compensation practices involving equity awards and subsequent tax-related share dispositions, rather than specific industry trends or competitive actions.

Stakeholder Impact

• Shareholders: The filing provides transparency into executive compensation and stock ownership, which can influence investor confidence and perception of management alignment.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to the vesting of Restricted Stock Units and subsequent tax withholding, executed under a Rule 10b5-1 plan. Such transactions are standard for executive compensation and do not provide new information about the company's operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

AMN Healthcare, Caroline Grace, Form 4, SEC Filing, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Compensation, Rule 10b5-1, CEO Stock Transactions